WHO ICTRP trial
Combined therapy of radiofrequency ablation with intratumoral dendritic cell…
JPRN-UMIN000001701 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000001701 |
|---|---|
| Public title | Combined therapy of radiofrequency ablation with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety |
| Scientific title | Combined therapy of radiofrequency ablation with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety - Combined therapy of radiofrequency ablation with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety |
| Primary sponsor | Kanazawa University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Hepatocellular carcinoma |
| Interventions | Immature dendritic cell treatment OK-432 stimulated dendritic cell treatment No cell treatment control |
| Registration date | Jan 4, 2012 |
| Target size | 36 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: